GABBIANI, CHIARA

GABBIANI, CHIARA  

CHIMICA "UGO SCHIFF" (attivo dal 01/08/1980 al 31/12/2012)  

Mostra records
Risultati 1 - 20 di 61 (tempo di esecuzione: 0.031 secondi).
Titolo Data di pubblicazione Autore(i) File
Activity of rat cytosolic thioredoxin reductase is strongly decreased by trans-[bs(2-amino-5- methylthiazole)tetrachlororuthenate(III)]: first report of relevant thioredoxin reductase inhibition for a ruthenium compound. 2007 P. MURA; M. CAMALLI; A. BINDOLI; F. SORRENTINO; A. CASINI; C. GABBIANI; P. ZANELLO; M.P. RIGOBELLO; L. MESSORI
Antiplasmodial Effects of a few Selected Natural Flavonoids and their Modulation of Artemisinin Activity 2008 A.R. Bilia; A.R. Sannella; F.F. Vincieri; L. Messori; A. Casini; C. Gabbiani ; C. Severini; G. Majori
Antitumor gold(III) complexes 2005 L. Messori; P. Orioli; C. Gabbiani
Biophysical characterisation of adducts formed between anticancer metallodrugs and selected proteins: new insights from x-ray diffraction and mass spectrometry studies. 2008 A. Casini; A. Guerri; C. Gabbiani; L. Messori
Chemistry and Biology of Two Novel Gold(I) Carbene Complexes as Prospective Anticancer Agents 2014 Messori L; Marchetti L; Massai L; Scaletti F; Guerri A; Landini I; Nobili S; Perrone G; Mini E; Leoni P; Pasquali M; Gabbiani C.
Chemistry, antiproliferative properties, tumor selectivity, and molecular mechanisms of novel gold(III) compounds for cancer treatment: a systematic study. 2009 A. Casini;G. Kelter;C. Gabbiani;M. A. Cinellu;G. Minghetti;D. Fregona;H. Fiebig;L. Messori
Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease. 2009 C. Grossi;S. Francese;A. Casini;M. C. Rosi;I. Luccarini;A. Fiorentini;C. Gabbiani;L. Messori;G. Moneti;F. Casamenti
Cytotoxic Profile and Peculiar Reactivity with Biomolecules of a Novel “Rule-Breaker” Iodidoplatinum(II) Complex 2010 Luigi Messori; Angela Casini; Chiara Gabbiani; Elena Michelucci; Leticia Cubo; Carla Rios-Luci; José M. Padron; Carmen Navarro-Ranninger; Adoracion G. Quiroga
DOTAP/DOPE and DC-Chol/DOPE lipoplexes for gene delivery studied by circular dichroism and other biophysical techniques 2007 L. Ciani; A. Casini; C. Gabbiani; S. Ristori; L. Messori; G. Martini;
ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme 2007 A. Casini; G. Mastrobuoni; A. Temperini; C. Gabbiani; S. Francese; G. Moneti; C.T. Supuran; A. Scozzafava; L. Messori
ESI MS characterization of protein adducts of anticancer ruthenium(II)-arene PTA (RAPTA) complexes 2007 A. Casini; G. Mastrobuoni; W.H. Ang; C. Gabbiani; G. Pieraccini; G. Moneti; P.J. Dyson; L. Messori
Exploiting soft and hard x-ray absorption spectroscopy to characterize metallodrug/protein interactions: the binding of [trans-rucl4(im)(dimethylsulfoxide)][imH] (im = imidazole) to bovine serum albumin 2008 I. Ascone; L. Messori; A. Casini; C. Gabbiani; A. Balerna; F. Dell'unto; A.C. Castellano
Exploring metal complexes-protein/peptide interactions by high resolution mass spectrometry 2009 Elena Michelucci, Chiara Gabbiani, Angela Casini, Giuseppe Pieraccini, Gloriano Moneti, Daniela Valensin, Luigi Messori
Exploring metallodrug-protein interactions by mass spectrometry: comparisons between platinum coordination complexes and an organometallic ruthenium compound. 2009 A. Casini;C. Gabbiani;E. Michelucci;G. Pieraccini;G. Moneti;P. J. Dyson;L. Messori
Exploring Metallodrug–Protein Interactions by ESI Mass Spectrometry: The Reaction of Anticancer Platinum Drugs with Horse Heart Cytochrome c 2006 A. Casini; C. Gabbiani; G. Mastrobuoni; L. Messori; G. Moneti; G. Pieraccini
Exploring the biochemical mechanisms of cytotoxic gold compounds: a proteomic study. 2010 F. Magherini; A. Modesti; L. Bini; M. Puglia; I. Landini; S. Nobili; E. Mini; M.A. Cinellu; C. Gabbiani; L. Messori
Exploring the biochemical mechanisms of cytotoxic gold compounds: a proteomic study. 2010 Magherini F; Modesti A; Bini L; Puglia M; Landini I; Nobili S; Mini E; Cinellu MA; Gabbiani C; Messori L.
Exploring the interactions between phosphane-based platinum(II) dichlorides and cytochrome c by electrospray ionization high resolution mass spectrometry 2011 Michelucci E., Mügge C., Gabbiani C., Boscaro F., Messori L., Weigand W.
Exploring the interactions of a “rule-breaker” iodo-platinum(II) complex with cytochrome c by mass spectrometry 2010 Michelucci E., Messori L., Casini A., Gabbiani C., Moneti G., Cubo L., Ríos-Luci C., Padrón J. M., Navarro-Ranninger C., Quiroga A. G.
fac-Ru(CO)(3)(2+) selectively targets the histidine residues of the beta-amyloid peptide 1-28. Implications for new Alzheimer's disease treatments based on ruthenium complexes. 2010 D. Valensin; P. Anzini; E. Gaggelli; N. Gaggelli; G. Tamasi; R. Cini; C. Gabbiani; E. Michelucci; L. Messori; H. Kozlowski; G. Valensin